Simultaneous resolution of febuxostat and diclofenac potassium in pure form and in their multi-ingredient formula. | ||||
| Azhar International Journal of Pharmaceutical and Medical Sciences | ||||
| Article 7, Volume 1, Issue 3, November 2021, Page 75-83 PDF (822.29 K) | ||||
| Document Type: Original research articles | ||||
| DOI: 10.21608/aijpms.2021.79525.1080 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Shimaa Mahmoud  1; Fatma Fouad1; Amira EL-Kosasy2
| ||||
| 1Department of pharmaceutical analytical chemistry, Faculty of Pharmacy (Girls), AL-Azhar University, Cairo, Egypt | ||||
| 2Department of Pharmaceutical Analytical Chemistry Faculty of Pharmacy, Ain-Shams University, Cairo, Egypt | ||||
| Abstract | ||||
| Easy, precise, and accurate three spectrophotometric procedures for successive resolution of febuxostat and diclofenac potassium in their multi-ingredient formula without prior separation were established and validated. Second derivative (2 D), dual-wavelength (DW), and ratio subtraction (RS) are the names of these procedures. They showed good linearity in the ranges of 2.0-20.0 µg/mL for febuxostat and 5.0–50.0 µg/mL for diclofenac potassium with strong determination coefficients (r2 ). For 2 D (r2 = 0.9995 - 0.9998), DW (r 2 = 0.9997 -0.9998) and RS (r2 = 0.9995 - 0.9999) for febuxostat and diclofenac potassium; respectively. By using the proposed procedures, the limits of detection and the limits of quantitation for febuxostat and diclofenac potassium were 0.135–0.580 µg/mL and 0.408–1.756 µg/mL, respectively. They were also successfully used to test two drugs in their multi-ingredient formula, with the findings being checked, statistically analyzed, and found to be consistent with those obtained by a previously published method. | ||||
| Keywords | ||||
| Keywords: Febuxostat; diclofenac; dual-wavelength; second derivative; ratio subtraction | ||||
|
Statistics Article View: 251 PDF Download: 347 |
||||
